Icon (ICLR) Invested Capital (2009 - 2026)
Icon's (ICLR) quarterly Invested Capital came in at $12.8 billion in Q2 2026, down 1.13% year-over-year from $12.9 billion in Q2 2025, and up 0.57% quarter-over-quarter from $12.7 billion in Q1 2026.
Analysis
Icon (ICLR) Invested Capital (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Invested Capital for 14 consecutive years, with $12.8 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Invested Capital fell 1.13% year-over-year to $12.8 billion in Q2 2026; TTM through Jun 2026 was $12.8 billion, a 1.13% decrease from a year earlier, with the FY2025 full-year figure at $12.6 billion, down 2.56% from the prior year.
- Invested Capital was $12.8 billion for Q2 2026 at Icon, up from $12.7 billion in the prior quarter.
- Over five years, Invested Capital peaked at $17.9 billion in Q1 2024 and troughed at $12.6 billion in Q4 2025.
- A 5-year average of $13.5 billion and a median of $13.1 billion in 2022 frame the typical range for Invested Capital.
- Across the five-year window, Invested Capital soared 746.57% in 2022 and fell 28.04% in 2025, its largest moves.
- Over 5 years, Invested Capital stood at $13.2 billion in 2022, then soared by 33.57% to $17.6 billion in 2023, then decreased by 26.57% to $12.9 billion in 2024, then retreated by 2.56% to $12.6 billion in 2025, then climbed by 1.37% to $12.8 billion in 2026.
- The last three Invested Capital figures came in at $12.8 billion (Q2 2026), $12.7 billion (Q1 2026), and $12.6 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 22.30 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 12.77 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 5.47 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 1.58 Bn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 1.33 Bn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.77 Bn |
| Mar 31, 2026 | 12.70 Bn |
| Dec 31, 2025 | 12.60 Bn |
| Sep 30, 2025 | 12.74 Bn |
| Jun 30, 2025 | 12.91 Bn |
| Mar 31, 2025 | 12.85 Bn |
| Dec 31, 2024 | 12.93 Bn |
| Sep 30, 2024 | 13.21 Bn |
| Jun 30, 2024 | 13.02 Bn |
| Mar 31, 2024 | 17.85 Bn |
| Dec 31, 2023 | 17.61 Bn |
| Sep 30, 2023 | 13.00 Bn |
| Jun 30, 2023 | 13.11 Bn |
| Mar 31, 2023 | 13.14 Bn |
| Dec 31, 2022 | 13.18 Bn |
| Sep 30, 2022 | 13.09 Bn |
| Jun 30, 2022 | 13.19 Bn |
| Mar 31, 2022 | 13.21 Bn |
| Dec 31, 2021 | 13.50 Bn |
| Sep 30, 2021 | 13.90 Bn |